Latest From Aposense Ltd.
An analysis by START-UP reveals that newly public companies are raising more money (on average) than comparable companies who remained private, even if total dollars for the pool of public firms is dwarfed by the total amount raised by their private brethren.
- Nanotechnology, Chips, etc.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
- Diagnostic Imaging Equipment & Supplies
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Neurology, Nervous System
- NST NeuroSurvival Technologies Ltd.
- Middle East
- Parent & Subsidiaries
- Aposense Ltd.
- Senior Management
Yoram Ashery, CEO
Dovi Farkash, CFO
Miri Ben-Ami, MD, VP, Clin. Dev. & Reg. Affairs
- Contact Info
Phone: (972) 3 924 72 11
5-7 Odem St.
P.O. Box 7119 Petach-Tikva , 49170
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.